Middle East Tech Today
SEE OTHER BRANDS

The best science and technology news from the Middle East

Middle East Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.

Press releases published on May 15, 2025

Longevity Health Holdings Announces Business Updates

Longevity Health Holdings Announces Business Updates

PITTSBURGH and GAITHERSBURG, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on extending human longevity and healthy aging through technologically innovative and clinically proven products in …

OSS Appoints Lieutenant General David Bassett (Ret.) Board Member

OSS Appoints Lieutenant General David Bassett (Ret.) Board Member

Former Director of the Defense Contract Management Agency brings decades of defense acquisition and modernization expertise to support OSS’s AI and edge compute growth opportunities ESCONDIDO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. …

Duos Edge AI Confirms EDC Deployment Goal in 2025

Duos Edge AI Confirms EDC Deployment Goal in 2025

JACKSONVILLE, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), through its operating subsidiary Duos Edge AI, Inc. (“Duos Edge AI”), a provider of adaptive, versatile and streamlined Edge Data …

BombBomb Launches Engage, a New Video Messaging Platform

BombBomb Launches Engage, a New Video Messaging Platform

COLORADO SPRINGS, Colo., May 15, 2025 (GLOBE NEWSWIRE) -- BombBomb, the video messaging company for sales professionals, announces the launch of Engage, an enterprise-class platform designed to help sales pros cut through inbox noise with face-to-face …

Reflect Scientific Advances Market Presence by Transitioning from OTCQB to OTCIQ

Reflect Scientific Advances Market Presence by Transitioning from OTCQB to OTCIQ

OREM, Utah, May 15, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of innovative cryogenic technologies for the life sciences and biotech industries, today announced that it is actively transitioning from the OTCQB Venture …

Moore & Giles Elevates Customer Experience and Brand Agility with BigCommerce

Moore & Giles Elevates Customer Experience and Brand Agility with BigCommerce

AUSTIN, Texas, May 15, 2025 (GLOBE NEWSWIRE) -- BigCommerce (Nasdaq: BIGC), an open SaaS, composable ecommerce platform for fast-growing and established B2C and B2B brands and retailers, today announced that Moore …

Pacira BioSciences Presents New Data on the Effects of Clinical Immunogenicity on Locally Administered PCRX-201 in Patients with Moderate to Severe Osteoarthritis of the Knee

Pacira BioSciences Presents New Data on the Effects of Clinical Immunogenicity on Locally Administered PCRX-201 in Patients with Moderate to Severe Osteoarthritis of the Knee

-- Early clinical data indicates that Pre-existing and treatment-induced anti-Ad5 neutralizing antibodies do not impact the safety and effectiveness of PCRX-201 – -- An oral presentation of the data to be featured at the ASGCT Annual Meeting -- BRISBANE, …

Cidara Therapeutics to Host Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza on May 22, 2025

Cidara Therapeutics to Host Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza on May 22, 2025

SAN DIEGO, May 15, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that it will host a …

First Procedures Completed with EndoQuest’s Endoluminal Surgical System in PARADIGM Trial

First Procedures Completed with EndoQuest’s Endoluminal Surgical System in PARADIGM Trial

Houston, TX, May 15, 2025 (GLOBE NEWSWIRE) -- EndoQuest Robotics, Inc., a pioneering leader in the development of endoluminal robotic surgical technology, announced today the completion of the first procedures of its pivotal clinical trial, Prospective …

Soleno Therapeutics Announces Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at PES 2025

Soleno Therapeutics Announces Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at PES 2025

REDWOOD CITY, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced poster presentations from its VYKATTM XR …

Cerence to Participate in Two Upcoming Investor Conferences

Cerence to Participate in Two Upcoming Investor Conferences

BURLINGTON, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that the company will participate in two upcoming investor conferences. …

BioVie Enrolls First Patient in ADDRESS-LC Clinical Trial Assessing Novel Anti-Inflammatory Candidate Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

BioVie Enrolls First Patient in ADDRESS-LC Clinical Trial Assessing Novel Anti-Inflammatory Candidate Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

Despite growing recognition of long COVID as a serious condition, diagnosed patients have no approved treatment options, with many suffering from debilitating fatigue and brain fog Evidence suggests sustained inflammation plays a central role in the …

Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI

Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Pathos AI, a leading AI-driven biotech company applying cutting-edge artificial intelligence to drug development, today announced its $365 million Series D financing, bringing its post-money valuation to …

Cocrystal Pharma Reports First Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

Cocrystal Pharma Reports First Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

In vitro testing with CDI-988 demonstrated superior broad-spectrum antiviral activity against major norovirus variants BOTHELL, Wash., May 15, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial …

HVR Launches “Utility Now!” Campaign at the Debut of Global Web3 Event Series — Not the One to Miss

HVR Launches “Utility Now!” Campaign at the Debut of Global Web3 Event Series — Not the One to Miss

TORONTO, May 15, 2025 (GLOBE NEWSWIRE) -- As Consensus Toronto draws the world’s leading voices in blockchain and decentralized finance, Not the One to Miss is where many of Web3’s most ambitious builders and personalities will be heading after hours. …

Nuvini Group Completes Acquisition of B2B SaaS Platform Munddi

Nuvini Group Completes Acquisition of B2B SaaS Platform Munddi

~ Successfully Marks the First of Four Anticipated Acquisitions in 2025 ~ ~ Creates New Synergies to Drive Revenue Growth and Enhance NVNI’s Ecosystem of B2B SaaS Solutions across Latin America ~ NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Nuvini Group …

Fresca Group Selects insightsoftware to Transform its Financial Consolidation and Disclosure Management Processes

Fresca Group Selects insightsoftware to Transform its Financial Consolidation and Disclosure Management Processes

RALEIGH, N.C., May 15, 2025 (GLOBE NEWSWIRE) -- insightsoftware, the most comprehensive provider of solutions for the Office of the CFO, today announced Fresca Group, one of the UK’s largest fresh produce businesses, will deploy JustPerform from …

Vaxart Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial

Vaxart Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial

SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it has received approval from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic …

Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults

Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults

Brekiya® becomes the first and only DHE autoinjector that allows patients to self-administer the same medication used in hospitals in a ready-to-use form Product will be available for appropriate patients in the second half of 2025 BRIDGEWATER, N.J., May …

Christophe Girardier, CEO of Glimpact, to Speak at Three Public Events During hub.brussels’ Impact Mission 2025 in New York

Christophe Girardier, CEO of Glimpact, to Speak at Three Public Events During hub.brussels’ Impact Mission 2025 in New York

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Christophe Girardier, CEO of Glimpact the first platform for analyzing the overall systemic environmental impact of products and organizations, will speak at three public events hosted by hub.brussels during …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service